India’s Breakthrough in Tackling Drug-Resistant Pneumonia: Nafithromycin Revolutionizes Antibiotic Therapy
In a landmark achievement for India’s biotechnology sector, the Union Minister Dr. Jitendra Singh unveiled the country’s first indigenously developed antibiotic, Nafithromycin, designed to combat drug-resistant pneumonia. Launched under the trade name “Miqnaf” by Wockhardt Pharmaceuticals, this groundbreaking drug offers a revolutionary treatment for Community-Acquired Bacterial Pneumonia (CABP), a condition that significantly impacts children, the…
